Relates to the availability of opioid reversal agents

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 2 Compare versions History 16 Sponsors

A265A — · 840 words Open full page ↗

STATE OF NEW YORK

________________________________________________________________________

265--A

2025-2026 Regular Sessions

IN ASSEMBLY

(Prefiled)

January 8, 2025

___________

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.

Create a free account Sign in

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Passed First Chamber — base rate 16%, measured from NY's completed sessions
Momentum +6 76/100 from the pace of recorded action
Time since last action -22 281 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.